Johnson & Johnson Vaccine May Cause Guillain-Barre Syndrome

Authorities warn the vaccine may have link to rare neurological complication

Johnson & Johnson Vaccine May Cause Guillain-Barre Syndrome
Can the Johnson & Johnson Vaccine Cause Guillain-Barre Syndrome?

Fear is spreading concerning Johnson & Johnson’s COVID-19 vaccines after authorities warned that it may increase the risk of developing Guillain-Barre syndrome, a rare neurological disorder. On Monday, the DFA in the US updated its labels to warn about the possible risks of the disease.


Regarding this, the FDA issued a statement, “Today, the FDA is announcing revisions to the vaccine recipient and vaccination provider fact sheets for the Johnson & Johnson (Janssen) COVID-19 Vaccine to include information pertaining to an observed increased risk of Guillain-Barre Syndrome following vaccination.”

According to the updated label, authorities are now suggesting that during the 42 days vaccination period, a person may have an increased risk of developing the Guillain-Barre syndrome.

With that, the label further adds that the evidence is currently not sufficient to establish a direct cause and effect relationship. However, there might be some association between the two.


What is Guillain-Barre syndrome?

In case you are wondering, the Guillain-Barre syndrome is a neurological disorder in which the immune system damages the body’s nerve cells resulting in muscle weakness. In extreme cases, it could lead to total paralysis.

Typically, the Guillain-Barre syndrome gets triggered because of a respiratory infection (sometimes a gastrointestinal infection). In case one experiences symptoms including tingling and weakness in the legs and arms after getting the vaccine, he/she should get medical attention right away.


Other common symptoms of the Guillain-Barre syndrome including difficulty chewing, speaking, walking, and swallowing. Some people might also experience bladder control issues and double vision.

Well currently, the single-dose Johnson & Johnson’s vaccine has not reached Australia despite the talks between the company and the government. Though a provisional approval was given to the vaccine by the TGA (Therapeutic Goods Administration) in Australia.


Regarding the risk of developing this syndrome, Johnson & Johnson stated, “The chance of having this occur is very low, and the rate of reported cases exceeds the background rate by a small degree.”

To check for a causal relationship, the FDA and CDC in the US continue to monitor cases of the syndrome in those who have received the vaccine.


In other news, The Mountain from Game of Thrones and former lifter Thor Bjornsson just underwent a major body transformation to kick-start his boxing career.


Share this on social media